IN THE NEWS Year None202220212020201920182016 Dec 18, 2019 Stopping Alzheimer's with a preventive vaccine? Dec 17, 2019 AC Immune Gets €28M from Eli Lilly as Alzheimer’s Drug Hits Phase I Dec 17, 2019 The Self-Protein Challenge Dec 17, 2019 How does TDP-43 bog up the brains of ALS, FTLD patients? AC Immune enlists Penn scientists to find out Dec 17, 2019 Vaccines for Alzheimer’s: exploiting similarities with Down syndrome Dec 17, 2019 A Belief that Early Interventions Will Be the Key to Treating Alzheimer’s Disease Dec 17, 2019 Insight Report: Potential Therapeutic Targets for Alzheimer’s Dec 16, 2019 AC Immune CEO Andrea Pfeifer provides an overview of her career to date and how her experience is helping to advance the company’s research Dec 16, 2019 Early Results on Alzheimer's Vaccine Trial in People with Down Syndrome Promising, Researchers Say Sep 23, 2019 To mark the World’s Alzheimer Day, Andrea Pfeifer shares AC Immune’s approach to developing new medicines with the newspaper Bilan First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Page 5 Next page next › Last page last »
